Cyteir Therapeutics (CYT) Stock Highlights

3.01 | +0%

2024-10-21 05:04:15

Cyteir Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing the next generation of precision oncology medicines that inhibit DNA damage repair and cause cancer cell death through a therapeutic strategy known as synthetic lethality. Its lead program is CYT-0851, which is designed to exploit a novel synthetic lethality between overexpression of a family of DNA damaging enzymes called cytidine deaminases and functional inhibition of homologous recombination, a DNA repair pathway critical for the survival of some cancers. Its Pre-clinical program is CYT-1853, which is designed to exploit the same novel synthetic lethality targeted by CYT-085.

Statistics

Range Today

3.01 3.01

Volume Today 0

Range 1 Year

1.67 3.19

Volume 1 Year 39.47M

Range 3 Year

1.13 23.1

Volume 3 Year 94.61M

Range 10 Year

1.13 23.1

Volume 10 Year 94.61M

Highlights

Market Capitalization 108.71M (small)

Floating Shares 10.83M

Current Price 3.01

Price To Earnings -3.26

Price To Book 0.87

Earnings Per Share -0.93

Payout Ratio 0%

Performance

Latest 0%

1 Month 0%

3 Months -1.63%

6 Months -1.95%

1 Year +40.65%

3 Years -81.76%

5 Years -81.76%

10 Years -81.76%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.